PP98 Cost Effectiveness Of Positron Emission Tomography-Computed Tomography In The Detection Of Metastases Originating From Oral Squamous Cell Carcinoma

Introduction Oral squamous cell carcinoma (OSCC) is a public health issue due to late diagnosis, often caused by its initial silent manifestation and economic barriers. This leads to higher rates of metastasis and recurrence. Diagnosis is made through biopsy, followed by staging using imaging techniques such as neck or chest computed tomography (CT), neck magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET-CT) for metastasis detection. Methods A cost-effectiveness analysis was conducted using a decision tree model with a one-year time horizon and no discount rate applied. The model included estimates of direct costs related to OSCC management and used correct diagnosis as the main outcome. The approach was based on a comparative evaluation of costs and clinical outcomes, considering the resources available in the healthcare system. Data were extracted from reliable sources, ensuring the robustness of the results and their applicability to public health practices related to the management of patients with this neoplasm. Results PET-CT had an incremental cost of USD362.54, an incremental effectiveness of 0.17, and an incremental cost-effectiveness ratio (ICER) of USD2,122.33 for each correct diagnosis. PET-CT was classified as a non-dominated strategy, meaning it is economically viable for improving case identification. In contrast, neck MRI combined with chest CT had an ICER of −USD1,969.85 per correct diagnosis, indicating that it is a dominated strategy—less efficient and with an unfavorable cost-benefit when compared with other diagnostic alternatives. Conclusions PET-CT for detecting cervical and distant metastases in patients with OSCC had higher effectiveness but incurred greater costs than clinical strategies such as neck and chest CT or neck MRI combined with chest CT. While more precise, PET-CT is less favorable economically, presenting a trade-off between accuracy and cost.

Authors

Publication Details

Journal
International Journal of Technology Assessment in Health Care
Published
2025-12-01
DOI
https://doi.org/10.1017/s0266462325103164
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PP98 Cost Effectiveness Of Positron Emission Tomography-Computed Tomography In The Detection Of Metastases Originating From Oral Squamous Cell Carcinoma

Luciene Schluckebier, Katia Senna, Daniele Marques, Kátia Marie Simões e Senna
International Journal of Technology Assessment in Health Care
Head and Neck Cancer Studies
article

PP98 Cost Effectiveness Of Positron Emission Tomography-Computed Tomography In The Detection Of Metastases Originating From Oral Squamous Cell Carcinoma

Luciene Schluckebier, Katia Senna, Daniele Marques, Kátia Marie Simões e Senna
article en

Abstract

Introduction Oral squamous cell carcinoma (OSCC) is a public health issue due to late diagnosis, often caused by its initial silent manifestation and economic barriers. This leads to higher rates of metastasis and recurrence. Diagnosis is made through biopsy, followed by staging using imaging techniques such as neck or chest computed tomography (CT), neck magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET-CT) for metastasis detection. Methods A cost-effectiveness analysis was conducted using a decision tree model with a one-year time horizon and no discount rate applied. The model included estimates of direct costs related to OSCC management and used correct diagnosis as the main outcome. The approach was based on a comparative evaluation of costs and clinical outcomes, considering the resources available in the healthcare system. Data were extracted from reliable sources, ensuring the robustness of the results and their applicability to public health practices related to the management of patients with this neoplasm. Results PET-CT had an incremental cost of USD362.54, an incremental effectiveness of 0.17, and an incremental cost-effectiveness ratio (ICER) of USD2,122.33 for each correct diagnosis. PET-CT was classified as a non-dominated strategy, meaning it is economically viable for improving case identification. In contrast, neck MRI combined with chest CT had an ICER of −USD1,969.85 per correct diagnosis, indicating that it is a dominated strategy—less efficient and with an unfavorable cost-benefit when compared with other diagnostic alternatives. Conclusions PET-CT for detecting cervical and distant metastases in patients with OSCC had higher effectiveness but incurred greater costs than clinical strategies such as neck and chest CT or neck MRI combined with chest CT. While more precise, PET-CT is less favorable economically, presenting a trade-off between accuracy and cost.

International Journal of Technology Assessment in Health CareVol. 41(S1)
Openalex Percentile: Top 26%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.